Definitive Contract 75N92020C00034
Award Date
9/30/20
Potential Completion Date
3/29/23
Potential Value
$27M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Ellume USA LLC
Ultimate Awardee
Ellume PTY LTD
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Valencia, CA 91355, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. National Institute of Biomedical Imaging and Bioengineering, part of the Department of Health and Human Services, awarded a $16,239,965.00 firm fixed price contract to Mologic Inc., a foreign-owned for-profit organization, for the Rapid Acceleration of Diagnostics (RADx) Program Tech Project #7697: SARS-CoV-2 Antigen Home Test. This contract, which does not have a set-aside designation, aims to deliver the testing products through January 2025 from Mologic's facility in Bedford, New...
The National Institutes of Health (NIH) awarded a $92,645,361.50 firm-fixed-price contract to Quidel Corporation to provide rapid COVID-19 antigen test kits under the Rapid Acceleration of Diagnostics (RADx) initiative. The contract, which does not have a set-aside designation, runs through April 30, 2025 and requires Quidel to deliver the tests from its facilities in San Diego, California. Quidel is a manufacturer of medical diagnostics and supplies, and has received numerous federal...
This contract was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Luminostics Inc., a for-profit medical technology company. The $39,067,500.00 Firm Fixed Price contract is for the RADX-TECH program to develop and deliver a smartphone-based point-of-care test for rapid SARS-CoV-2 antigen detection from nasal swabs. This contract was not set aside for any particular business type. Luminostics has received prior federal contract and grant awards related to...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Definitive Firm Fixed Price contract to Qorvo Biotechnologies LLC, a subsidiary of Qorvo, Inc., to secure an Emergency Use Authorization (EUA) approved point-of-care (POC) antigen test system and increase the incremental daily cartridge production capacity to 54,800 tests. The contract, valued at $23,882,600.00, is part of the Rapid Acceleration of Diagnostic Testing (RADX)...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm-fixed price definitive contract worth $14,982,258.00 to Uh-Oh Labs Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract is for Uh-Oh Labs to provide its SARS-CoV-2 Loop-de-Loop™ assay for high-throughput and point-of-care use, supporting the agency's medical research efforts for rapid COVID-19 detection. The one-year base period...
This federal contract award to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, is for the development and delivery of a high-performance point-of-care antibody test to assess immunity to the SARS-CoV-2 virus and confirm positive antibody tests. The $275,000 Firm Fixed Price contract was awarded on June 17, 2020 by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services. This contract was not set aside...
The National Institutes of Health's National Heart, Lung and Blood Institute awarded Lumiradx, Inc. a $243,000 firm fixed-price purchase order to finalize development of its SARS-CoV-2 and influenza A/B test. As the prime contractor, Lumiradx will deliver its LumiraDx Platform test to the NIH for use in detecting the viruses that cause COVID-19 and seasonal flu. No subcontractors or set-aside designations were identified. This purchase order supports the NIH's ongoing efforts to expand...
The Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute awarded a $22.57 million firm fixed price definitive contract to Flambeau Diagnostics LLC of Monona, Wisconsin. The contract is for the delivery of RADX TECH 2375 point-of-need, saliva-based COVID-19 testing platforms over a twenty-month period ending in March 2023. No subcontractors or set aside designations were indicated. The award supports the NIH's ongoing efforts to...
This definitive contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Biomedical Imaging and Bioengineering is valued at $1,462,373.11 to Ubiquitome Limited of New Zealand. Under the contract, Ubiquitome will support the RADX program's goal of accelerating diagnostic testing for SARS-CoV-2 by developing the Liberty16 mobile real-time PCR test to make accurate Covid-19 lab testing accessible to all Americans. The firm fixed price...
This is a $97,492,572.50 definitive, firm-fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) to Quidel Corp, a manufacturer of medical diagnostics and supplies, for the procurement of over-the-counter (OTC) COVID-19 tests. The contract has an ultimate completion date of April 7, 2028 and does not use a set-aside designation. Quidel Corp, which is based in San Diego, California,...